Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

SZSE:300357.SZ

26.98 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009
Revenue 925.395848.19896.016807.692636.208639.353500.745385.577312.086267.106239.511193.61147.517103.17659.32837.407
Cost of Revenue 44.8140.18941.27834.43828.53722.85328.51814.08611.55513.1049.7327.3747.5596.4725.6894.529
Gross Profit 880.585808.001854.739773.254607.671616.5472.227371.491300.53254.002229.779186.235139.95896.70453.63832.878
Gross Profit Ratio 0.9520.9530.9540.9570.9550.9640.9430.9630.9630.9510.9590.9620.9490.9370.9040.879
Reseach & Development Expenses 119.88396.324106.01987.92764.87541.17113.4797.7029.23710.30110.99710.0885.7713.8183.9240
General & Administrative Expenses 14.26110.6875.5758.6847.5018.1368.848.6095.5575.27710.474.6637.6985.5473.8417.427
Selling & Marketing Expenses 208.368323.167311.811282.108223.655223.702168.288128.888114.49796.04488.69175.72655.93437.79923.32118.432
SG&A 222.628332.431317.386290.793231.156231.838177.128137.497120.054101.32299.16180.3963.63143.34627.16325.859
Other Expenses 168.96434.27216.07928.47216.93525.1861.6272.7460.3724.5296.5121.463.0452.762.070.028
Operating Expenses 511.475463.028439.484407.192312.965298.195218.648164.452150.537125.316121.962104.38778.76554.33935.74525.941
Operating Income 369.11344.973396.207392.905321.518343.375271.356216.223155.966134.123112.4181.69260.3641.17518.6369.779
Operating Income Ratio 0.3990.4070.4420.4860.5050.5370.5420.5610.50.5020.4690.4220.4090.3990.3140.261
Total Other Income Expenses Net -4.0480.9822.540.0921.0982.3411.6272.7460.3724.4946.4681.4193.0432.7592.050.027
Income Before Tax 365.062345.956398.747392.998322.616345.716272.982218.969151.832138.616118.87883.11163.40343.93420.6869.805
Income Before Tax Ratio 0.3940.4080.4450.4870.5070.5410.5450.5680.4870.5190.4960.4290.430.4260.3490.262
Income Tax Expense 60.72350.43363.02266.70952.89253.09641.11832.86522.63120.819.3312.569.6336.6692.281-0.708
Net Income 317.822310.185348.773337.991278.447298.297232.884186.104129.201117.8299.55570.56453.77437.26518.40610.513
Net Income Ratio 0.3430.3660.3890.4180.4380.4670.4650.4830.4140.4410.4160.3640.3650.3610.310.281
EPS 0.610.590.670.650.530.570.440.360.250.230.190.150.120.0790.0410.016
EPS Diluted 0.610.590.670.650.530.570.440.360.250.230.190.150.120.0790.0410.016
EBITDA 416.939391.094425.271422.413339.175328.67260.831225.491155.696132.846110.71886.73773.18753.33327.3129.113
EBITDA Ratio 0.4510.4610.4750.5230.5330.5140.5210.5850.4990.4970.4620.4480.4960.5170.460.244